🇺🇸 FDA
Patent

US 10588982

Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin

granted A61KA61K47/65A61K47/6803

Quick answer

US patent 10588982 (Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin) held by The Regents of the University of California expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K47/65, A61K47/6803, A61K47/68031, A61K47/6845